Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
$465 Mln
P/E Ratio
22.09
P/B Ratio
0.85
Industry P/E
--
Debt to Equity
--
ROE
0.04 %
ROCE
3.46 %
Div. Yield
8.74 %
Book Value
55.12
EPS
1.68
CFO
$68.35 Mln
EBITDA
$294.89 Mln
Net Profit
$362.24 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Blackrock Health Sciences Trust (BME)
| -5.09 | -6.08 | -8.28 | -7.07 | -8.14 | -2.30 | -1.70 |
|
BSE Sensex
| 0.39 | 6.40 | 1.96 | 7.69 | 10.43 | 20.75 | 10.61 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Blackrock Health Sciences Trust (BME)
| -6.20 | -7.16 | -10.37 | 7.51 | 18.64 | 24.04 | 6.35 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 13.76 | 1,441.70 | 7.52 | 10.88 | |
| 5.89 | 1,719.50 | 9.06 | 1.87 | |
| 19.56 | 5,478.09 | 9.36 | 8.69 | |
| 28.48 | 1,496.14 | 4.59 | 17.57 |
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of... companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States. Read more
Chief Compliance Officer and Anti-Money Laundering Officer
Mr. Charles Choon Sik Park
Chief Compliance Officer and Anti-Money Laundering Officer
Mr. Charles Choon Sik Park
Headquarters
New York, NY
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Blackrock Health Sciences Trust (BME) stood at $ 775 Mln as on 31-Dec-24
The share price of Blackrock Health Sciences Trust (BME) is $36.00 (NYSE) as of 17-Apr-2025 16:10 EDT. Blackrock Health Sciences Trust (BME) has given a return of -8.14% in the last 3 years.
Blackrock Health Sciences Trust (BME) has a market capitalisation of $ 465 Mln as on 17-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/E ratio of Blackrock Health Sciences Trust (BME) is 22.09 times as on 17-Apr-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Blackrock Health Sciences Trust (BME) and enter the required number of quantities and click on buy to purchase the shares of Blackrock Health Sciences Trust (BME).
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
The CEO & director of Mr. Charles Choon Sik Park. is Blackrock Health Sciences Trust (BME), and CFO & Sr. VP is Mr. Charles Choon Sik Park.
There is no promoter pledging in Blackrock Health Sciences Trust (BME).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
536
|
|
|
172
|
|
|
149
|
|
|
144
|
| Blackrock Health Sciences Trust (BME) | Ratios |
|---|---|
|
Return on equity(%)
|
3.46
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
97.44
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Blackrock Health Sciences Trust (BME) was No Profit.
$0.05
(
